	Catalent has over 80 years of softgel manufacturing experience, and continues to deliver innovation with technological enhancements, such as chewable softgels and coatings, and formulations to enable modified-release for Rx, OTC and consumer health products.

 is a lipid based softgel technology that enables macromolecules to be delivered orally and overcome permeability and stability challenges in a more easily administered form than intravenous injection. Enteric coatings enable targeted delivery of drugs and can limit degradation of the API in the stomach.

 platform enhances both drug therapeutic performance and patient experience. The technology allows for high-temperature encapsulation of semi-solid fill material within a non-gelatin, plant-based shell, and is ideal for the encapsulation of higher melting-point fill formulations, and the production of soft capsules containing semi-solid matrices for modified-release of poorly soluble and/or poorly permeable drug compounds.